The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy

Cardiovascular Drugs and Therapy

Volumn 23, Issue 1, 2009, Pages 5-15

  Nodari, Savina ^a   Metra, Marco ^a   Milesi, Giuseppe ^a   Manerba, Alessandra ^a   Cesana, Bruno Mario ^a   Gheorghiade, Mihai ^b   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Heart failure; N 3 PUFAs; Ventricular arrhythmias

Indexed keywords

ADRENALIN; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; DOPAMINE; FUROSEMIDE; ICOSAPENTAENOIC ACID ETHYL ESTER; INTERLEUKIN 1; INTERLEUKIN 6; NEBIVOLOL; NORADRENALIN; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; CATECHOLAMINES; CYTOKINES; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 58549111004     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-008-6142-7     Document Type: Article

References (57)

1. D Kim RA Duff 1990 Regulation of K+ channels in cardiac myocytes by free fatty acids Circ Res 67 1040 1046
2. JX Kang A Leaf 1996 Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins Proc Natl Acad Sci USA 93 3542 3546
3. JH Christensen P Gustenhoff E Korup 1996 Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial BMJ 312 677 678
4. JH Christensen E Korup J Aaroe 1997 Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction Am J Cardiol 79 1670 1673
5. S Bendahhou TR Cummins WS Agnew 1997 Mechanism of modulation of the voltage-gated skeletal and cardiac muscle sodium channels by fatty acids Am J Physiol 272 C592 C600
6. Dei Cas L, Nodari S. Ruolo degli acidi grassi poliinsaturi PUFA n-3 nella prevenzione della morte improvvisa. Basel: Excerpta Medica; 2003.
7. A Leaf JX Kang YF Xiao GE Billman 2003 Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 107 2646 2652
8. R De Caterina A Zampolli S Del Turco R Madonna M Massaro 2006 Nutritional mechanisms that influence cardiovascular disease Am J Clin Nutr 83 421S 426S
9. PC Calder 2004 n-3 fatty acids, inflammation, and immunity-relevance to postsurgical and critically ill patients Lipids 39 1147 1161
10. GE Billman H Hallaci A Leaf 1994 Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids Proc Natl Acad Sci USA 91 4427 4430
11. GE Billman JX Kang A Leaf 1999 Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs Circulation 99 2452 2457
12. SG Priori E Aliot C Blomstrom-Lundqvist 2001 Task force on sudden cardiac death of the European Society of Cardiology Eur Heart J 22 1374 1450
13. HC Bucher P Hengstler C Sdiindler G Meier 2002 N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials Am J Med 112 298 308
14. Gissi Prevenzione Investigators 1999 Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico Lancet 354 447 455
15. MH Raitt WE Connor C Morris 2005 Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial JAMA 293 2884
16. A Leaf CM Albert M Josephson 2005 Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake Circulation 112 2762 2768
17. IA Brouwer PL Zock AJ Camm 2006 Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators. The Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) Randomized Trial JAMA 295 2613 2619
18. DJA Jenkins AR Josse J Beyene P Dorian ML Burr R LaBelle 2008 Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis CMAJ 178 157 164
19. D Mozaffarian PK Stein RJ Prineas DS Siscovick 2008 Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults Circulation 117 1130 1137
20. SM Narayan 2006 T-wave alternans and the susceptibility to ventricular arrhythmias J Am Coll Cardiol 47 269 281
21. DJ Cantillon KM Stein SM Markowitz 2007 Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction J Am Coll Cardiol 50 166 173
22. ES Kaufman DM Bloomfield RC Steinman PB Namerow O Costantini RJ Cohen 2006 "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction J Am Coll Cardiol 48 1399 1404
23. T Klingenheben 2007 Microvolt T-wave alternans for arrhythmia risk stratification in left ventricular dysfunction: which patients benefit J Am Coll Cardiol 50 174 175
24. JM Smith EA Clancy CR Valeri 1988 Electrical alternans and cardiac electrical instability Circulation 77 110 121
25. T Klingenheben M Zabel RB D'Agostino 2000 Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure Lancet 356 651 652
26. P Savard JL Rouleau MD Ferguson 1997 Risk stratification after myocardial infarction using signal averaged electrocardiographic criteria adjusted for sex, age and myocardial infarction location Circulation 96 202 213
27. G Yi K Hnatkova NG Mahon PJ Keeling M Reardon AJ Camm 2000 Predictive value of wavelet decomposition of the signal-averaged electrocardiogram in idiopathic dilated cardiomyopathy Eur Heart J 21 1015 1022
28. PF Binkley E Nunziata GJ Haas SD Nelson RJ Cody 1991 Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model J Am Coll Cardiol 18 464 472
29. J Hayano S Mukai M Sakakibara A Okada K Takata T Fujinami 1994 Effects of respiratory interval on vagal modulation of heart rate Am J Physiol 267 H33 H40
30. DS Krantz HT Santiago WJ Kop CN Bairey Merz A Rozanski JS Gottdiener 1999 Prognostic value of mental stress testing in coronary artery disease Am J Cardiol 84 1292 1297
31. S Nodari M Metra L Dei Cas 2003 Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol Eur J Heart Fail 5 621 627
32. R Ferrari T Bacchetti R Confortini 1995 Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure Circulation 92 1479 1486
33. F Marangoni C Colombo C Galli 2004 A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies Anal Biochem 326 267 272
34. S Nazarian DA Bluemke AC Lardo 2005 Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2821 2825
35. RG Assomull SK Prasad J Lyne G Smith 2006 Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 1977 1985
36. AK Gehi RH Stein LD Metz 2005 Microvolt T-wave alternans fort he risk stratification of ventricular tachyarrhythmic events: a meta-analysis J Am Coll Cardiol 46 75 82
37. JA Taylor P Studinger 2006 Counterpoint: cardiovascular variability is not an index of autonomic control of the circulation J Appl Physiol 101 678 681
38. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology 1996 Heart rate variability. Standards of measurement, physiological interpretation, and clinical use Eur Heart J 17 354 381
39. G Parati G Mancia M Di Rienzo P Castiglioni 2006 Point: cardiovascular variability is/is not an index of autonomic control of circulation J Appl Physiol 101 676 678
40. HC Doval DR Nul HO Grancelli 1996 Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators Circulation 94 3198 3203
41. SN Singh SG Fisher PE Carson RD Fletcher Department of Veterans Affairs CHF STAT Invest 1998 Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy J Am Coll Cardiol 32 942 947
42. M Zecchin A Di Lenarda D Gregori 2005 Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy Ital Heart J 6 721 727
43. WF Hamer SA Rubin CT Peter 1994 Factors that predict syncope during ventricular tachycardia in patients Am Heart J 27 1102 1106
44. KK Steinback M Oliver K Frohner 1994 Hemodynamics during ventricular tachyarrhythmias Am Heart J 127 1102 1106
45. DS Echt PR Liebson LB Mitchell 1991 Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 781 788
46. CM Albert H Campos MJ Stampfer 2002 Blood levels of long-chain n-3 fatty acids and the risk of sudden death N Engl J Med 346 1113 1118
47. A Leaf YF Xiao JX Kang GE Billman 2005 Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias J Membr Biol 206 129 139
48. B London C Albert ME Anderson 2007 Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop Circulation 116 e320 e335
49. YF Xiao L Ma SY Wang ME Josephson GK Wang JP Morgan 2006 Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids Am J Physiol Cell Physiol 290 C362 C370
50. T Seidler G Hasenfuss LS Maier 2007 Targeting altered calcium physiology in the heart: translational approaches to excitation, contraction, and transcription Physiology (Bethesda) 22 328 334
51. YF Xiao Q Ke Y Chen JP Morgan A Leaf 2004 Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells Biochem Biophys Res Commun 321 116 123
52. M Canetti MW Akhter A Lerman IS Karaalp JA Zell H Singh 2003 Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy Am J Cardiol 92 1246 1249
53. M Metra S Nodari G Parrinello 2007 The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T Eur J Heart Fail 9 776 786
54. D Mozaffarian A Geelen IA Brouwer JM Geleijnse PL Zock MB Katan 2005 Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials Circulation 112 1945 1952
55. P Nerheim S Birger-Botkin L Piracha B Olshansky 2004 Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia Circulation 110 247 252
56. M Chonchol I Goldenberg AJ Moss S McNitt AK Cheung 2007 Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction Am J Nephrol 27 7 14
57. R Marchioli GISSI-Prevenzione investigators 2001 Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione Trial Eur Heart J Suppl 3 D85 D97